While Eli Lilly’s LLY top-line continues to touch new sky highs thanks to its blockbuster GLP-1 medicines — Mounjaro (for ...

Wall Street analysts remain bullish on Eli Lilly, boasting an Average Brokerage Recommendation (ABR) of 1.46, largely between ...

Meadow Creek Wealth Advisors LLC decreased its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 7.7% during the ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

The average brokerage recommendation (ABR) for Lilly (LLY) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after ...

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

The History Channel has been highlighting the origin stories of some of the most successful businesses and household names in varying industries with The Mega-Brands That Built America. Season 3 ...

Discover reviews, ratings, and trailers for The Book of Eli on Rotten Tomatoes. Stay updated with critic and audience scores today!

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...

As Medadvisor's divestment deal today attests, foreign acquirers are on the hunt for undervalued local assets.